Association Between the Volume Transfer Constant (Ktrans) From Dynamic Contrast‐Enhanced Perfusion MR and HER2 Status in Breast Cancer Brain Metastases

ABSTRACT Background With the development of new human epidermal growth factor 2 (HER2)‐targeting therapies, a non‐invasive method of determining the HER2 status of breast cancer brain metastases can be of great clinical value, particularly given the risks of brain biopsy and the possibility of disco...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jonathan R. Young, Luke N. Ledbetter, Julie A. Ressler, Mark S. Shiroishi, Joanne E. Mortimer, Daniel Schmolze, Mariko Fitzgibbons, Bihong T. Chen
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2025-10-01
Saila:	Cancer Reports
Gaiak:	brain metastasis breast cancer dynamic contrast‐enhanced (DCE) perfusion magnetic resonance imaging volume transfer constant (Ktrans)
Sarrera elektronikoa:	https://doi.org/10.1002/cnr2.70354
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!